You Make the Call: Readers' Response

You Make the Call: Readers' Response

How readers responded to this month's You Make the Call question


Disclaimer: ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

You Make the Call

Reader Responses: Should a mostly asymptomatic patient with amyloidosis receive systemic therapy?

Here’s how readers responded to a You Make the Call question about whether a mostly asymptomatic patient with amyloidosis should receive systemic therapy. Disclaimer: ASH...
You Make the Call

Reader Responses: How long should a young patient with COVID-19 and pulmonary embolism receive...

Here’s how readers responded to a You Make the Call question about anticoagulation for a young patient with COVID-19 and pulmonary embolism. Disclaimer: ASH does...
You Make the Call

Reader Responses: How would you treat a patient with aggressive systemic mastocytosis?

Here’s how readers responded to a You Make the Call question about treatment of bone manifestations and transplantation for systemic mastocytosis. Disclaimer: ASH does not...
You Make the Call

Reader Responses: How would you treat this patient with poor cytogenetics and low-grade B-cell...

Here’s how readers responded to a You Make the Call question about treatment of low-grade B-cell lymphoma with high-risk cytogenetics. Disclaimer: ASH does not recommend or...
You Make the Call

Reader Responses: Which direct oral anticoagulant would you choose for a submassive pulmonary embolism?

Here’s how readers responded to a You Make the Call question about choice of direct oral anticoagulant (DOAC) for a saddle pulmonary embolism. Disclaimer: ASH...
You Make the Call

Reader Responses: Can I start cytoreductive therapy in a patient with low-risk polycythemia vera?

Here’s how readers responded to a You Make the Call question about cytoreductive therapy in a patient with low-risk polycythemia vera. Disclaimer: ASH does not...
You Make the Call

Reader Responses: How would you treat this patient with JAK2-positive essential thrombocythemia?

Here’s how readers responded to a You Make the Call question about anticoagulation in a patient with essential thrombocythemia. Disclaimer: ASH does not recommend or...
You Make the Call

Reader Responses: Is hypogammaglobulinemia alone an indication for treatment for CLL?

Here’s how readers responded to a You Make the Call question about whether hypogammaglobulinemia alone is an indication for treatment of CLL. Disclaimer: ASH does...
You Make the Call

Reader Responses: Is 3 months of anticoagulation enough for a provoked VTE?

Here’s how readers responded to a You Make the Call question about the appropriate length of anticoagulation for a provoked DVT. Disclaimer: ASH does not...
You Make the Call

Reader Responses: Should a pregnant patient with hemochromatosis receive iron?

Here’s how readers responded to a You Make the Call question about the treatment of iron deficiency during pregnancy in a patient with hereditary...
Advertisement

Current Issue

May 2021 Volume 7 Issue 6

This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.

Block title